Abstract: An operating table control apparatus is disclosed. The operating table control apparatus has a control device, a plurality of operating table components, and an operating table drive. The plurality of operating table components are actuatable from a first position to a second position via the operating table drive. The second position is a preset position that is stored by the operating table control apparatus. The second position is assigned to a control element of the control device.

Abstract: A patient support apparatus includes a bed frame having a head end and a foot end and control circuitry carried by the bed frame. The control circuitry receives information about conditions of the patient support apparatus. A light is coupled to the bed frame adjacent the foot end and is coupled to the control circuitry. The light is in a first state when the patient support apparatus is operating normally and the light is in a second state when the control circuitry detects an alert condition.

Abstract: A therapeutic support device includes a bladder having one or more independently inflatable compartments, each including a plurality of inflatable cells. When inflated, each inflatable cell forms a contact node that may support a user or another object disposed thereon. The inflatable compartments can be alternately inflated and deflated such that contact pressure can be applied to and relieved from corresponding portions of the user's body in an alternating manner.

Abstract: A leg elevating device is provided that is formed from foam, an air bladder, or supportive sheets of material with straps or supports. The device elevates a user's legs when laying down such that the device has a front, a back, a first side and a second side. The device has a bottom surface having and a top surface located above the bottom surface, the top surface extending upward from a front edge, and two side edges toward to form a curved shaped. The one or more apexes are located above a back edge or above a middle of the bottom surface. The top surface ends at the back of the support material at a top surface back edge. Depending on the configuration a back surface connects to the back edge of the bottom surface, and extends upward to connect to the back of the top surface.

Abstract: A patient transport device includes an inflatable torso support and one or more straps coupled to sides of the inflatable torso support. Each strap can be configured at least as a single loop. A strap concealment device can be coupled to the inflatable torso support to span a major face of the inflatable torso support. The strap concealment device can include a central panel spanning the major face and one or more side panels extending from a perimeter of the central panel. The one or more side panels can terminate at an edge distally disposed from the central panel at a bunch-gathering binding. The one or more side panels can be selectively foldable between a first position concealing the inflatable torso support and some or all of the one or more straps and a second position exposing the inflatable torso support and the one or more straps.

Abstract: An infant holding device, including an infant holding portion, including a ductile sheet covered with infant-compatible material and a stand portion, adapted to support the infant holding portion in a vertically diagonal position, so that the infant holding portion thereby has a top and a bottom. In one preferred embodiment the ductile sheet is made of aluminum. In an additional preferred embodiment the infant holding portion is separable from the stand portion.

Abstract: A medical trolley cart having a main housing with an interior chamber. The main housing has front, back, first side, second side, top and bottom panels. A front door on the front of said main housing provides accessing an interior chamber, which may have a plurality of sliding shelves. A rear door on the rear of said main housing provides access to a rear portion of the interior chamber or to a second chamber within the cart. The rear door has a hinge around which the door is opened and a latch for holding the rear door in a closed position. The rear door opens to a maximum point at which the rear door forms an angle of 15-40 degrees with the main housing.

Abstract: A leg muscle, abdominal muscle, and spinal exercise device adapted for imparting curvature to a lumbar or sacral spine of a user and for manipulating the spine and intervertebral discs with decompression force includes a frame for placement on a floor. The frame has a top surface and a bottom surface, wherein the top surface and bottom surface are in a spaced apart relationship forming a hollow portion there between. At least one inflatable bladder is carried by the top surface of the frame. A body strap attachment passes through the frame in non-fixed relationship and is partially disposed within the hollow portion for encompassing the user's thoracic-sacral spinal region and securing said frame. An elongate stirrup strap member is attachable to the body strap attachment thereby connecting to the user's spinal region. A stirrup is attachable to the stirrup strap member distal end.

Abstract: In one embodiment of the tissue massage devices and methods described herein, a tissue massage device can include a base configured to be grasped in a user's hand such that a first surface at a proximal end of the device abuts against the user's palm. The device can also include a massage head extending from a second surface of the base that is distal to the first surface, the massage head having a generally convex shape and including a textured non-slip surface formed on a distal portion thereof. The textured non-slip surface can prevent sliding motion between the device and a user's skin, thereby causing sliding between subcutaneous fascia and muscle that is therapeutic.

Abstract: In some embodiments, a system and/or method may include an inner wearable harness worn, during use, on a torso of a subject which includes a flexible vest. The system may include a plurality of engines, each of which are contained in a flexible container, which when activated apply an oscillation force. The system may include a positioning system which allows positioning the flexible container such that the oscillation force is applied to at least one treatment area of the subject. The oscillation force may mobilize, during use, at least some secretions in an airway within the subject substantially adjacent the treatment area. The system may include an outer harness worn, during use, on a torso of a subject. The outer wearable harness, when activated, adjusts the oscillation force applied by at least some of the activated plurality of engines to the treatment area by providing a compressive force.

Abstract: In some embodiments, a system may include a first wearable harness worn, during use, on a torso of a subject. The system may include a second wearable harness worn, during use, on a torso of a subject on an outer surface of the first wearable harness. The system may include a plurality of engines which when activated apply an oscillation force to at least one treatment area. At least one of the plurality of engines may be releasably couplable to the first wearable harness using a positioning system such that the oscillation force is applied to the treatment areas. The oscillation force may mobilize, during use, at least some secretions in an airway within the subject at least adjacent the treatment area. The second wearable harness, when activated, may provide a compressive force to at least some of the activated plurality of engines positioned above the treatment area.

Abstract: A sterile hand connection device is used to attach a patient's arm to a cable adaptor of a surgical arm positioning apparatus. The cable adaptor is connected to two cable ends of a cable of the surgical arm positioning apparatus. The hand connection includes a clip, a buckle, and a wrap that is mounted to the clip. The buckle is attached to the cable adaptor and the clip snaps onto the buckle. The hand wrap is mounted to the clip and wraps around a patient's hand, wrist, and forearm.

Abstract: A surgical arm positioning system has a cable including two end portions coupled to a connection member of a hand grip. The cable and connection member form a continuous loop. The surgical arm positioning system further includes a frame that supports a number of pulleys. The continuous loop is trained around the pulleys. The surgical arm positioning system also includes a tensile resistance member engaged with the cable. The tensile resistance member provides tensile force to the cable to resist movement of the continuous loop relative to the frame, thereby to hold the patient's arm relatively still during surgery.

Abstract: Provided is an assistance device comprising a hard sheath that simulates an erect penis and that has on the end thereof an air-bleed hole, and a soft skin that covers the entire hard sheath and that has an air-bleed hole at a position that is slightly offset from the air-bleed hole of the hard sheath, and the device has added thereto a valve function due to the two air-bleed holes.

Abstract: A compression therapy device for vascular diseases and other therapies comprising a bladder a lever arm acting on the outer surface of the bladder such that cyclical operation of an actuator on the lever arm creates cyclical changes in pneumatic pressure in the therapeutic portion of the bladder.

Abstract: A massage device massages various parts of the body. The device includes a plurality of attachment members each configured for attachment to a particular body part. Each of a plurality of massage units is coupled to an associated one of the attachment members. Each massage unit comprises a substantially planar face, a plurality of sockets coupled to and extending into the planar face, and a plurality of contact members. Each contact member is positioned in and extends from an associated one of the sockets wherein an outer portion of each contact member extends from the planar face. Each massage unit has a plate abutting a base of each socket. The plate is selectively vibrated wherein each contact member vibrates. Each of a plurality of control units is coupled to an associated one of the attachment members. Each massage unit is operationally coupled to an associated one of the control units.

Abstract: Disclosed herein is a device comprising a casing; at least one vibratory source; at least one power source; elements to actuate the vibratory source; electrical communication between the vibratory source, the power source, and other elements; and an optional thermal element for modulating the temperature of a contacted area of a surface. Also disclosed herein are methods for using the device.

Abstract: In some embodiments, a system may include an inner wearable harness worn, during use, on a torso of a subject. The system may include a plurality of engines which when activated apply an oscillation force. The system may include a positioning system which allows positioning at least one of the plurality of engines on the inner wearable system such that the oscillation force is applied to at least one treatment area of the subject. The oscillation force may mobilize, during use, at least some secretions in an airway within the subject substantially adjacent the treatment area. The system may include an outer harness worn, during use, on a torso of a subject. The outer wearable harness, when activated, adjusts the oscillation force applied by at least some of the activated plurality of engines to the treatment area.

Abstract: In some embodiments, a kit may include systems allowing for clearing a biological airway. The kit may include an inner wearable system worn, during use, on a torso of a subject. The kit may include a plurality of engines which when activated apply an oscillation force to at least one treatment area of the subject. At least one of the plurality of engines may be releasably couplable to the inner wearable system. The oscillation force may be applied to at least one of the treatment areas of the subject such that the oscillation force mobilizes, during use, at least some secretions in an airway within the subject at least adjacent the treatment area. The kit may include an outer wearable system worn, during use, on a torso of a subject which when activated, adjusts the oscillation force. The kit may include one or more batteries and/or a control unit.

Abstract: In some embodiments, a system may include an inner wearable harness including a flexible vest. The system may include at least one engine which when activated apply an oscillation force. The at least one engine is positioned after the vest has been positioned on the subject on different areas of the inner wearable harness to allow selective placement of engines on and/or adjacent areas of the subject's chest such that the oscillation force is applied to at least one treatment area. The oscillation force may mobilize, during use, at least some secretions in an airway within the subject substantially adjacent the treatment area. The system may include a flexible and elastic outer harness worn, during use, on a torso of a subject which when activated provides a compressive force to adjust the oscillation force applied by at least some of the at least one engine to the treatment area.

Abstract: In some embodiments, a method may include clearing a biological airway. The method may include positioning an inner wearable harness on a torso of a subject. The method may include selectively positioning at least some of a plurality of engines on and/or adjacent at least one treatment area. At least one of the plurality of engines may be releasably couplable to the inner wearable harness. The method may include positioning an outer wearable harness on a torso of a subject. The method may include applying an oscillation force to at least one of the treatment areas using at least some of the plurality of engines. The method may include adjusting the applied oscillation force to the treatment area by activating the outer wearable harness. The method may include mobilizing at least some secretions in an airway within the subject substantially adjacent the at least one treatment area.

Abstract: Methods and apparatus for improving emergency wash systems. Various embodiments pertain to compact, low flow emergency eyewash systems that provide tepid water at low flow rates. Still further embodiments pertain to emergency washing systems that are adapted and configured to reduce the exposure of users to Legionnaire's Disease with washing system features that permit quick, efficient, high flow rate flushing of the plumbing providing water to the washing system. Still further embodiments pertain to emergency eyewash systems that provide tepid water from a thermostatically controlled mixing valve that has a multi-function body.

Abstract: The present invention is based, at least in part, on the identification of a pharmaceutical container formed, at least in part, of a glass composition which exhibits a reduced propensity to delaminate, i.e., a reduced propensity to shed glass particulates. As a result, the presently claimed containers are particularly suited for storage of pharmaceutical compositions and, specifically, a pharmaceutical solution comprising a pharmaceutically active ingredient, for example, LEVEMIR, NOVOLOG, NOVOLIN 70-30, NOVOLIN R, NOVOLIN N, NOVOLOG MIX 70-30 and NOVOLIN L.

Abstract: The present invention is based, at least in part, on the identification of a pharmaceutical container formed, at least in part, of a glass composition which exhibits a reduced propensity to delaminate, i.e., a reduced propensity to shed glass particulates. As a result, the presently claimed containers are particularly suited for storage of pharmaceutical compositions and, specifically, a pharmaceutical solution comprising a pharmaceutically active ingredient, for example, PROCRIT (epoetin alfa), REMICADE (Infliximab) or DORIBAX (doripenem).

Abstract: A medication dispensing assembly includes a canister that has an outer wall extending between a top end and a bottom end of the canister. The top end of the canister is open so the canisters may contain a medication. A lid is coupled to the top end of the canister. A processor is coupled to the canister. A timer is coupled to the canister and the processor. The timer determines a trigger time that the medication is to be removed from the canister. An actuator is coupled to the canister and the processor. The actuator is actuated to determine the trigger time. An alarm is coupled to the canister and the processor. A sensor is coupled to the canister and the processor. The alarm continuously emits an audible alarm until the sensor detects that the lid is positioned in the open position.

Abstract: Zirconia dental ceramics exhibiting opalescence and having a grain size in the range of 10 nm to 300 nm, a density of at least 99.5% of theoretical density, a visible light transmittance at or higher than 45% at 560 nm, and a strength of at least 800 MPa.

Abstract: A method of making a machinable puck of a hard, solvent free, substantially non-hydrophilic polyurethane elastomer for use in fabricating dental appliances. The elastomer has a hardness of not less than about Shore D65. A first polyester or polyether polyol with a functionality greater than two and a molecular weight greater than one hundred is reacted with an isocyanate prepolymer prepared from one or more branched polyester or polyether polyols with a functionality greater than two; and then blending prepolymer and first polyester or polyether polyol with nanoparticles and colorants as needed. In one embodiment, the polypropylene glycol triether and the isocyanate prepolymer comprises dicyclohexylmethane 4,4?-diisocyanate. The machined, elastomer appliance is able to be heated in hot water to make it flexible and formable for individual, customed-fitting for the patient.

Abstract: A dental jacket made of a hard, solvent free, substantially non-hydrophilic polyurethane elastomer. The jacket elastomer has a hardness of not less than about Shore D65. A polyester or polyether polyol with a functionality greater than two and a molecular weight greater than one hundred is reacted with an isocyanate prepolymer prepared from one or more branched polyester or polyether polyols with a functionality greater than two; and then blending prepolymer and first polyester or polyether polyol with nanoparticles. In one embodiment, the polypropylene glycol triether and the isocyanate prepolymer comprises dicyclohexylmethane 4,4?-diisocyanate.

Abstract: A two-component tooth whitening system containing a bleaching gel and an activating gel, including that the system has both thermo- and foaming-stability for non-refrigerated storage. The admixing of the two components provides effective whitening and proper bubbling that enables oxygen and free radicals released to diffuse into tooth enamel, and thus, provides significant whitening efficacy.

Abstract: The invention relates to the cosmetic use, by oral administration, of a combination of active agents including petroselinic acid and zinc, in particular the salts of Zn (II) wherein said salts are preferably complexed by one or more (poly)hydroxyacids such as zinc gluconate, for improving hair quality and for preventing and controlling the microinflammation of hair follicles, in particular for controlling hair aging in men over the age of 30 or in women.

Abstract: The invention relates to the cosmetic use, by oral administration, of a combination of active agents including at least petroselinic acid and at least one active agent selected from among taurine, arginine, cysteine, zinc, a salt thereof, and lycopene, for improving the quality of nails, specifically the microvascularization of the nails, in particular in pre-hypertensive individuals.

Abstract: Disclosed is an aqueous cleansing composition comprising (a) at least one anionic surfactant that is not an alkyl sulfate or alkyl ether sulfate, (b) at least one amphoteric surfactant, (c) at least one thickener selected from a hydrophobically-modified acrylic acid based copolymer having a molecular weight from about 80,000 to about 2,500,000 grams per mole, (d) at least one cationic conditioning agent, and (e) optionally at least one nonionic surfactant; wherein the ratio of the anionic surfactant (a) to amphoteric surfactant (b) is less than about 9.5, by weight. Also disclosed are methods of cleaning and conditioning hair using said compositions and methods of making said compositions.

Abstract: A cationic compatible metal oxide and oral care compositions containing the metal oxide are disclosed. Preferably, the oral care compositions contain a cationic compatible metal oxide and a cationic ingredient, such as for example, a cationic antibacterial agent such as cetyl pyridinium chloride (“CPC”). The cationic compatible metal oxide, e.g. silica, comprise metal oxide particles having a subtantially negative surface charge and a vitamin deposited onto or reacted with the surface of the metal oxide particles in an amount sufficient to provide a substantially positive surface charge on the metal oxide particle. Processes for making and using the vitamin modified metal oxide in oral care compositions are also disclosed.

Abstract: An allantoin-containing skin cream composition can comprise allantoin and at least one anionic or nonionic emulsifier that is substantially hydrophilic and is soluble in water. The composition is in the form of an oil-in-water emulsion. The pH of the composition is in a range of from about 3.0 to about 6.0; preferably, the pH of the composition is from about 5.0 to about 6.0. The composite can further comprise an acidic anionic polymer. A preferred acidic anionic polymer is a carboxypolymethylene polymer. The composition can further comprise a carbohydrate polymer such as galactoarabinan, polygalactose or polyarabinose. The composition can additionally comprise other ingredients such as herbal extracts, an antioxidant component, an emollient component, a chelator, a solvent component or a preservative component. The composition is useful as a skin protectant.

Abstract: The present invention is directed to a method of achieving improved hair volume comprising applying to hair a composition comprising from about 0.25% to about 80% of a pre-emulsified emulsion comprising from about 0.005% to about 80% of one or more materials selected from the group comprising metathesized unsaturated polyol esters, sucrose polyesters, fatty esters with a molecular weight greater than or equal to 1500 and mixtures thereof or, by weight of said hair care composition; wherein an emulsifier is selected from the group consisting of anionic, non-ionic, cationic, amphoteric and mixtures thereof wherein the average particle size of the pre-emulsified emulsion is from about 20 nanometers to 20 microns; from about 5% to about 50% of one or more anionic surfactants, by weight of said hair care composition; from about 0.

Abstract: Disclosed is a hair care composition comprising: a discrete particle comprising an oily component, wherein the oily component comprises one or more materials selected from the group consisting of: (A) metathesized unsaturated polyol esters; (B) sucrose polyesters; (C) fatty esters with a molecular weight greater than or equal to 1500; and mixtures thereof, wherein the oily component has a Zero Shear Viscosity at 25° C. of from about 102 Pa·s to about 109 Pa·s, and has a melting point of from about 35° C. to about 60° C.; and wherein the discrete particle has an average particle size in the hair care composition of from about 0.5 microns to about 20 microns. The hair care composition provides improved conditioning benefits, clean feel, and/or hair styling benefit.

Abstract: In an embodiment, the present invention is directed a method of achieving hair volume and combability comprising applying to hair a personal care composition comprising from about 0.25% to about 80% of a pre-emulsified emulsion comprising from about 0.005% to about 80% of one or more materials selected from the group comprising metathesized unsaturated polyol esters, sucrose polyesters, fatty esters with a molecular weight greater than or equal to 1500 and mixtures thereof or, by weight of said hair care composition; wherein an emulsifier is selected from the group consisting of anionic, non-ionic, cationic, amphoteric and mixtures thereof wherein the average particle size of the pre-emulsified emulsion is from about 20 nanometers to 20 microns; from about 5% to about 50% of one or more anionic surfactants, by weight of said hair care composition; from about 5% to about 40% of a gel matrix comprising: (i) from 0.1% to 30% of one or more fatty alcohols, by weight of the gel matrix; (ii) from 0.

Abstract: The present invention concerns the use of perfluoropolyether phosphates, in particular perfluoropolyether diphosphates, as stabilizing agents for polyphenols in cosmetic and/or dermatological compositions for topical application, and it also concerns cosmetic and/or dermatological compositions containing polyphenols and optionally vitamin E and free ascorbic acid, stabilized by perfluoropolyether diphosphates.

Abstract: Systems and/or methods of treating and/or preventing nail disorders are disclosed herein. Also, disclosed herein are systems and/or methods of improving the appearance of a nail. A preferred embodiment of the present invention comprises a method of treating and/or preventing a nail disorder in a subject comprising topically applying a composition comprising a poly(urea-urethane)polymer and/or a poly(urea-urethane) pre-polymer to a nail of said subject, thereby treating and/or preventing said nail disorder.

Abstract: The present invention relates to an essential oil of Satureja montana comprising more than 60% by weight of geraniol and more than 5% by weight of trans-?-caryophyllene, in particular of Satureja montana L. ssp. variegata. The present invention also relates to the cosmetic use of an essential oil of Satureja montana comprising more than 60% by weight of geraniol and more than 5% by weight of trans-?-caryophyllene, in particular of Satureja montana L. ssp. variegata, for treating greasy skin and/or preventing greasy or greasy-prone skin and/or the associated aesthetic skin defects.

Abstract: In certain embodiments, the invention is directed to a formulation for providing skin tightening which includes two or more of the following agents: red split lentils, Multani Mitti, charoli, chandan powder, and turmeric powder. Two or more of the agents can be ground and combined together in an effective amount. The combined agents can be additionally combined with a topical excipient.

Abstract: Disclosed are compositions and methods for their use that can be used in cosmetic applications. The composition can include an effective amount of a Centella asiatica stem cells to reduce the activity of hyaluronidase in skin, an effective amount of tetradecyl aminobutyroylvalylamino butyric urea trifluoroacetate or Alpinia galanga leaf extract to promote the production of hyaluronic acid in skin, an effective amount of tripeptide-1 to promote the production of fibronectin and laminin in skin, and a dermatologically acceptable vehicle.

Abstract: The invention relates to the use of a substance for restoring normal co-expression and interaction between the LOX and NRAGE proteins. The invention relates in particular to the use of an effective amount of at least one substance that modulates the expression and/or activity of the LOX of SEQ ID NO: 1 and/or that modulates the expression and/or activity of the NRAGE of SEQ ID NO: 2 for modulating the interaction between the LOX and NRAGE proteins to regulate the balance between the cellular proliferation, differentiation and apoptosis, particularly in cases where the balance between these phenomena is disturbed, and especially in cases where the interaction between LOX and NRAGE is absent or altered. The invention makes it possible to treat skin ageing, lichen planus, graft-versus-host reaction (GVH), eczema, psoriasis and a cancer, particularly an epithelial cancer and more particularly a cutaneous epithelial cancer of basocellular or spinocellular type.

Abstract: The invention discloses an article for swaddling in the mouth to deliver pharmacologically active substances, particularly nicotine, in combination with dyes or flavorings, across the buccal membranes when said article is swaddled in the mouth. The article comprises a non-edible substantially cylindrical core element, such as a toothpick, and the indicator element may be a bulb, trinket, insignia or other marking. In a preferred embodiment, the invention makes a social statement about the beneficial uses of nicotine. Methods for using the invention to mitigate sensations of nervousness and boredom are also disclosed.

Abstract: The present invention provides liposome compositions containing substituted ammonium and/or polyanion, and optionally with a desired therapeutic or imaging entity. The present invention also provide methods of making the liposome compositions provided by the present invention.

Abstract: Solid pharmaceutical dosage form for the release of at least one Active Pharmaceutical Ingredient (API) in the oral cavity comprising a core coated by at least one film coating. The core comprises at least one API. One or more organoleptically disturbing sensations induced by one or several of the APIs and/or of inactive components of the solid pharmaceutical dosage form is/are reduced by constituents of said film coating. Said constituents comprise at least one film-forming polymer and at least one flavoring agent or at least one sweetener.

Abstract: The invention relates to oral pharmaceutical compositions containing flibanserin, methods for the preparation thereof and use thereof as a medicament.

Abstract: The present invention includes compositions, methods, systems and kits for the controlled delivery of an active agent within a polymeric network upon the binding of a molecule that decreases the structural integrity of the polymeric network at one or more micro- or nanovacuoles.

Abstract: The present invention provides abuse deterrent mucoadhesive devices for delivery of buprenorphine. Each device comprises a mucoadhesive layer and a backing layer, and the pH in each layer is selected, such that absorption of buprenorphine is maximized.

Abstract: A pharmaceutical dosage form includes an effective amount of L-menthol for treating a gastrointestinal disorder. The L-menthol is within a plurality of particulates having a core including crystalline L-menthol dissolved in a terpene-based essential oil. A proteinaceous coating of a continuous film of proteinaceous material is over the core.